[Major depression in consumers of benzodiazepines]. 1998

C Ortiz Valle, and J López-Torres Hidalgo, and C Santos Rodríguez, and J Montoya Fernández, and A Maroto de Agustín, and F Escobar Rabadán
Centro de Salud Zona IV, Albacete.

OBJECTIVE To determine the proportion of benzodiazepines consumers who present a mayor depressive disorder and to observe the clinical evolution after restoring an antidepressive treatment. METHODS An observational design with a transversal character to determine the prevalence of the depression and a pre and after intervention to observe the answer to the treatment. METHODS Primary Care. METHODS Patients of the Centro de Salud Zona IV of Albacete who consume benzodiazepines (size of the sample: 91 subjects, selected by means of a consecutive pattern in three medical offices of general practice). METHODS To install an antidepressive treatment. RESULTS We explored the presence of nuclear symptoms of depression by means of a interview. The other analyzed variables were: the cognitive state, the characteristics of the consume of benzodiazepines, the problems of health, the intake of other medicines, the frequentation, the installation of the antidepressive treatment and the sociodemographic characteristics. The patients diagnosed of mayor depression were interviewed again after one month and after three months. 37 patients presented criterion of mayor depression (40.7%) (CI 95%: 30.5-51.5). In these an antidepressive treatment was restored, corresponding to selective serotonin reuptake inhibitors in the 91.9% of the occasions. The proportion of depressive patients was higher in women (p = 0.04) and under the diagnosed people we observed a lower period of benzodiazepines consume (p = 0.02), although with a much higher daily consume (p = 0.01). Among the 37 patients who initiated the treatment, only 7 presented adverse reaction. 28 patients were appraised after one month, presenting 6 of them 5 or more nuclear symptoms of depression. CONCLUSIONS The high proportion of mayor depressive frames can justify the systematic investigation of such disorder in benzodiazepines consumers, specially in women and in patients with a high intake. The identification of the nuclear symptoms can be considered as a useful technique to orientate a mayor depression and to evaluate also the results of an antidepressive treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds

Related Publications

C Ortiz Valle, and J López-Torres Hidalgo, and C Santos Rodríguez, and J Montoya Fernández, and A Maroto de Agustín, and F Escobar Rabadán
June 2019, The Cochrane database of systematic reviews,
C Ortiz Valle, and J López-Torres Hidalgo, and C Santos Rodríguez, and J Montoya Fernández, and A Maroto de Agustín, and F Escobar Rabadán
September 2013, Journal of affective disorders,
C Ortiz Valle, and J López-Torres Hidalgo, and C Santos Rodríguez, and J Montoya Fernández, and A Maroto de Agustín, and F Escobar Rabadán
April 1990, Drug and alcohol dependence,
C Ortiz Valle, and J López-Torres Hidalgo, and C Santos Rodríguez, and J Montoya Fernández, and A Maroto de Agustín, and F Escobar Rabadán
November 2011, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
C Ortiz Valle, and J López-Torres Hidalgo, and C Santos Rodríguez, and J Montoya Fernández, and A Maroto de Agustín, and F Escobar Rabadán
September 2019, The journal of ECT,
C Ortiz Valle, and J López-Torres Hidalgo, and C Santos Rodríguez, and J Montoya Fernández, and A Maroto de Agustín, and F Escobar Rabadán
September 1993, Nederlands tijdschrift voor geneeskunde,
C Ortiz Valle, and J López-Torres Hidalgo, and C Santos Rodríguez, and J Montoya Fernández, and A Maroto de Agustín, and F Escobar Rabadán
December 1986, The American journal of psychiatry,
C Ortiz Valle, and J López-Torres Hidalgo, and C Santos Rodríguez, and J Montoya Fernández, and A Maroto de Agustín, and F Escobar Rabadán
January 1985, British journal of clinical pharmacology,
C Ortiz Valle, and J López-Torres Hidalgo, and C Santos Rodríguez, and J Montoya Fernández, and A Maroto de Agustín, and F Escobar Rabadán
November 1991, Hospital & community psychiatry,
C Ortiz Valle, and J López-Torres Hidalgo, and C Santos Rodríguez, and J Montoya Fernández, and A Maroto de Agustín, and F Escobar Rabadán
January 1991, Journal of substance abuse treatment,
Copied contents to your clipboard!